Bank of America’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Buy |
217,967
+47,617
| +28% | +$69K | ﹤0.01% | 5033 |
|
|
2025
Q1 | $235K | Buy |
170,350
+20,236
| +13% | +$27.9K | ﹤0.01% | 5126 |
|
|
2024
Q4 | $456K | Buy |
150,114
+52,903
| +54% | +$161K | ﹤0.01% | 4786 |
|
|
2024
Q3 | $484K | Buy |
97,211
+53,429
| +122% | +$266K | ﹤0.01% | 4678 |
|
|
2024
Q2 | $256K | Buy |
43,782
+13,603
| +45% | +$79.6K | ﹤0.01% | 4955 |
|
|
2024
Q1 | $240K | Sell |
30,179
-7,625
| -20% | -$60.5K | ﹤0.01% | 4970 |
|
|
2023
Q4 | $220K | Buy |
37,804
+37,604
| +18,802% | +$219K | ﹤0.01% | 5115 |
|
|
2023
Q3 | $512 | Hold |
200
| – | – | ﹤0.01% | 6377 |
|
|
2023
Q2 | $500 | Hold |
200
| – | – | ﹤0.01% | 6420 |
|
|
2023
Q1 | $420 | Sell |
200
-34
| -15% | -$71 | ﹤0.01% | 6545 |
|
|
2022
Q4 | $362 | Buy |
+234
| New | +$362 | ﹤0.01% | 6645 |
|
|
2022
Q1 | – | Sell |
-189
| Closed | -$1K | – | 7706 |
|
|
2021
Q4 | $1K | Buy |
+189
| New | +$1K | ﹤0.01% | 7209 |
|